Best TWAS P=3.05e-14 · Best GWAS P=1.4e-10 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | NPM3 | 0.03 | 0.01 | lasso | 2 | 0.03 | 1.2e-04 | -6.05 | 5.2 | 2.0e-07 | -0.10 | 0.01 | 0.95 | TRUE |
2 | GTEx | Adipose Subcutaneous | CYP17A1-AS1 | 0.05 | 0.02 | enet | 10 | 0.03 | 2.8e-03 | 3.64 | 6.2 | 7.1e-10 | -0.43 | 0.04 | 0.88 | FALSE |
3 | GTEx | Artery Coronary | CYP17A1-AS1 | 0.20 | -0.01 | enet | 21 | 0.04 | 2.3e-02 | 1.14 | 6.0 | 1.8e-09 | -0.31 | 0.05 | 0.33 | FALSE |
4 | GTEx | Brain Cerebellar Hemisphere | ARL3 | 0.15 | 0.02 | enet | 18 | 0.11 | 1.1e-03 | -6.23 | 6.4 | 1.3e-10 | -0.72 | 0.04 | 0.70 | FALSE |
5 | GTEx | Brain Cerebellum | ARL3 | 0.20 | 0.09 | enet | 32 | 0.07 | 3.7e-03 | 4.98 | 7.3 | 3.3e-13 | -0.52 | 0.10 | 0.77 | FALSE |
6 | GTEx | Brain Cortex | CYP17A1-AS1 | 0.15 | 0.13 | lasso | 7 | 0.14 | 1.3e-04 | 4.98 | 6.5 | 8.1e-11 | -0.71 | 0.06 | 0.80 | FALSE |
7 | GTEx | Brain Hypothalamus | CYP17A1-AS1 | 0.34 | 0.10 | lasso | 10 | 0.05 | 2.6e-02 | 6.24 | 6.4 | 1.7e-10 | -0.51 | 0.04 | 0.73 | FALSE |
8 | GTEx | Brain Nucleus accumbens basal ganglia | CYP17A1-AS1 | 0.39 | 0.22 | lasso | 3 | 0.19 | 8.2e-06 | 5.04 | 5.4 | 6.1e-08 | -0.41 | 0.09 | 0.62 | FALSE |
9 | GTEx | Breast Mammary Tissue | CYP17A1-AS1 | 0.10 | -0.01 | enet | 28 | 0.00 | 2.4e-01 | 6.23 | 5.6 | 2.7e-08 | -0.62 | 0.03 | 0.84 | FALSE |
10 | GTEx | Breast Mammary Tissue (Male) | CYP17A1-AS1 | 0.06 | 0.00 | lasso | 3 | 0.01 | 2.1e-01 | -5.36 | 5.3 | 1.4e-07 | -0.75 | 0.03 | 0.27 | FALSE |
11 | GTEx | Breast Mammary Tissue (Female) | TMEM180 | 0.18 | 0.06 | lasso | 4 | 0.07 | 4.5e-03 | -4.01 | -5.7 | 1.1e-08 | 0.73 | 0.16 | 0.50 | FALSE |
12 | GTEx | Cells Transformed fibroblasts | TMEM180 | 0.05 | 0.04 | lasso | 2 | 0.01 | 3.3e-02 | -5.50 | 5.5 | 3.6e-08 | -0.90 | 0.11 | 0.65 | FALSE |
13 | GTEx | Esophagus Mucosa | SUFU | 0.08 | 0.02 | enet | 18 | 0.01 | 4.2e-02 | -3.06 | -5.9 | 4.6e-09 | 0.70 | 0.24 | 0.68 | TRUE |
14 | GTEx | Esophagus Muscularis | SUFU | 0.07 | 0.04 | enet | 18 | 0.03 | 5.2e-03 | -3.78 | -6.1 | 1.2e-09 | 0.76 | 0.12 | 0.79 | FALSE |
15 | GTEx | Liver | ACTR1A | 0.15 | 0.00 | lasso | 10 | 0.00 | 4.6e-01 | -5.55 | -7.0 | 2.0e-12 | 0.22 | 0.06 | 0.18 | FALSE |
16 | GTEx | Liver | TMEM180 | 0.28 | 0.17 | enet | 36 | 0.17 | 1.7e-05 | -5.29 | -7.6 | 3.1e-14 | 0.83 | 0.08 | 0.90 | TRUE |
17 | GTEx | Lung | CYP17A1-AS1 | 0.06 | 0.08 | lasso | 3 | 0.06 | 1.6e-05 | 5.04 | 5.5 | 4.8e-08 | -0.46 | 0.05 | 0.94 | FALSE |
18 | GTEx | Nerve Tibial | CYP17A1-AS1 | 0.14 | 0.08 | lasso | 6 | 0.06 | 7.2e-05 | 5.03 | 5.3 | 1.1e-07 | -0.43 | 0.42 | 0.35 | FALSE |
19 | GTEx | Pancreas | NPM3 | 0.20 | 0.15 | lasso | 4 | 0.07 | 5.4e-04 | -5.79 | 5.7 | 1.1e-08 | -0.13 | 0.04 | 0.92 | FALSE |
20 | GTEx | Skin Sun Exposed Lower leg | SUFU | 0.06 | 0.05 | enet | 12 | 0.06 | 8.4e-06 | -5.29 | 5.3 | 8.7e-08 | -0.90 | 0.22 | 0.77 | TRUE |
21 | GTEx | Skin Sun Exposed Lower leg | ACTR1A | 0.08 | 0.06 | enet | 10 | 0.07 | 2.7e-06 | -5.51 | 6.7 | 2.4e-11 | -0.83 | 0.08 | 0.91 | FALSE |
22 | GTEx | Testis | NPM3 | 0.13 | 0.15 | lasso | 3 | 0.13 | 2.5e-06 | -5.79 | 5.8 | 7.6e-09 | -0.14 | 0.03 | 0.96 | FALSE |
23 | NTR | Blood | ACTR1A | 0.03 | 0.03 | enet | 19 | 0.03 | 1.4e-09 | -3.78 | 5.4 | 7.3e-08 | -0.67 | 0.98 | 0.02 | FALSE |
24 | ROSMAP | Brain Pre-frontal Cortex | POLL | 0.08 | 0.05 | blup | 299 | 0.06 | 4.4e-08 | 3.50 | 6.0 | 1.6e-09 | -0.13 | 0.99 | 0.01 | FALSE |
25 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C10orf26 | 0.03 | 0.02 | enet | 5 | 0.02 | 1.6e-04 | -5.31 | -5.4 | 7.7e-08 | 0.78 | 0.27 | 0.70 | TRUE |
26 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SFXN2 | 0.12 | 0.09 | lasso | 4 | 0.10 | 4.4e-19 | 5.40 | -5.3 | 1.2e-07 | 0.25 | 0.30 | 0.70 | FALSE |
27 | The Cancer Genome Atlas | Esophageal Carcinoma | SFXN2 | 0.26 | 0.02 | blup | 48 | 0.10 | 4.9e-04 | 5.40 | -6.1 | 1.4e-09 | 0.33 | 0.02 | 0.64 | FALSE |
28 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | NPM3 | 0.04 | 0.02 | blup | 22 | 0.02 | 1.8e-03 | -6.01 | 5.2 | 2.6e-07 | -0.03 | 0.00 | 0.64 | TRUE |
29 | The Cancer Genome Atlas | Brain Lower Grade Glioma | NPM3 | 0.02 | 0.03 | lasso | 3 | 0.02 | 9.2e-04 | -5.79 | 6.0 | 2.6e-09 | -0.14 | 0.01 | 0.82 | FALSE |
30 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | SFXN2 | 0.20 | 0.08 | blup | 48 | 0.13 | 9.3e-07 | 5.40 | -5.3 | 1.1e-07 | 0.20 | 0.13 | 0.82 | FALSE |
31 | The Cancer Genome Atlas | Lung Adenocarcinoma | TMEM180 | 0.08 | 0.07 | blup | 52 | 0.09 | 1.9e-10 | -5.29 | 5.3 | 1.2e-07 | -0.77 | 0.02 | 0.98 | FALSE |
32 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | TMEM180 | 0.05 | 0.02 | blup | 52 | 0.04 | 1.5e-05 | -5.56 | 5.2 | 1.7e-07 | -0.74 | 0.02 | 0.95 | FALSE |
33 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SUFU | 0.03 | 0.02 | blup | 90 | 0.02 | 1.5e-02 | -5.50 | -5.3 | 1.1e-07 | 0.89 | 0.04 | 0.59 | FALSE |
34 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | TMEM180 | 0.13 | 0.03 | blup | 52 | 0.02 | 5.7e-02 | 0.86 | 5.5 | 4.6e-08 | -0.57 | 0.02 | 0.28 | FALSE |
35 | The Cancer Genome Atlas | Prostate Adenocarcinoma | TMEM180 | 0.16 | 0.27 | lasso | 4 | 0.27 | 4.3e-28 | -5.27 | -5.3 | 1.4e-07 | 0.85 | 0.02 | 0.98 | FALSE |
36 | The Cancer Genome Atlas | Stomach Adenocarcinoma | SFXN2 | 0.15 | 0.10 | enet | 9 | 0.11 | 2.4e-08 | 5.33 | -5.4 | 6.7e-08 | 0.28 | 0.41 | 0.59 | FALSE |
37 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | C10orf76 | 0.19 | 0.20 | lasso | 1 | 0.18 | 4.6e-07 | -5.79 | -5.8 | 7.2e-09 | 0.13 | 0.02 | 0.98 | TRUE |
38 | The Cancer Genome Atlas | Thyroid Carcinoma | C10orf26 | 0.06 | 0.05 | lasso | 5 | 0.04 | 4.1e-05 | 5.02 | -5.2 | 1.7e-07 | 0.34 | 0.11 | 0.81 | FALSE |